Comparison of three testkits Q-NASBA, amplicor-H IV monitor, quantiplex HIV RNA} for determining HIV-1 RNA copy number (viral load) in plasma;Vergleich von drei testkits (Q-NASBA, amplicor-HIV monitor, quantiplex HIV R N A) zur bestimmung der HIV-1 RNA kopienzahl (virusbeladung) im plasma

Immunitat und Infektion

Volumn 25, Issue 3, 1997, Pages 99-104

  Grabnitz F ^a   Klehr Martinelli, M ^a   Tiller, F W ^a  

^a Medizinisch Immunologische Laboratorien   (Germany)

Author keywords

Amplicor hiv monitor; Bdna. Comparison and evaluation; Hiv 1 rna quantification; Hiv j infection; Q NASBA; Qpcr; Quantiplex hiv 1 assay

Indexed keywords

EID: 4244128222     PISSN: 03401162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Boom, R, Sol. C. J. A., Sakimans, M. M. M., Jansen, C. L, Wertheim-vanDillen. P. M. E., van der Nordaa, J.:A rapid and simple method for purification of nucleic acids, J. Clin. Microbiol. 28, 495-503 (1990)
2. Branson, B. M.: Early intervention for persons infected with human immunodeficiency virus. Clin. Infect Dis. 20 [Suppl 1), 3-22 [1995)
3. Cao. Y. Qin, L, Zhang, L. Safrit, J., Ho, D. D.: Virologie and immunologie characterization of longterm survivors of human immunodeficiency virus type 1 infection. New EngJ. J. Med. 332, 201-208 (1995)
4. Clementi, M., Menzo, S., Bagnarelli, P., Valenza, A, Paolucci, S., Sampaolesi, R, Manzin, A., Varaldo. P. E.: Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection, Clin. Microbiol. Rev. 9, 135147 0996)
5. Dewar, R, Highbarger, H. C., Sarmiento, M. D., Todd, J. A, Vasudchevari, M. B., Davey, R. T., Kovasc, J. A, Salzman, N. P., Lane H. C., Urdea, M. S.: Application of branched UNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J. Infect Dis 170, 1172-1179(1994)
6. B Dickover, R E.. Garratty, E. M., Hermann, S. A, Sim, M. S., Plaeger, S., Boyer. P. J., Keller, M., Dveikis, A, Stiehm, R, Bryson, Y: Identification of levels of maternal HIV-1 RNA associated with risk of per/natal transmission. J. Amer. Med. Assoc..275, 599-605 (1996)
7. Ho, D. D., Neumann, A U., Perelson, A S., Chen, W., Leonard, J. M., Markowitz, M.: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373,123-126(1995)
8. Ho, D. D.: Wal counts in HIV infection. Science 272. 1124-1125(1996)
9. Holodny, M., Katzenstein, D. A, Sengupta, S., Wang, A M., Casipit, C., Schwartz, D. H., Konrad, M., Groves, E., Merigan, T. C. Detection and quantification of human immunodeficiency virus RNA in patient serum by use ofpolymerase chain reaction. J. InfectDis. 163, 862-866 (1991)
10. Holodny, M., Mole, L., Yen-Lieberman, B., Margolis, D., Starkey, C., Carroll, R, Spahlinger, T., Todd, J., Jackson, J. B.: Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in Vacutainer CPT, Vacutainer PPT, and standard Vacutainer tubes. J. Clin. Microbiol. 33, 1562-1566 (1995)
11. Katzenstein, T. L, Pedersen, C., Nielsen, C., Lundgren, J. D., Jacobsen, P. H., Gerstoff, J.: Longitudinal serum HIV RNA quantification: Correlation to viral phenotype at seroconversion and clinical outcome. AIDS 10, 167-173 (1996)
12. Kievits, T., Van Gemen, B.. Van Strijp, D., Schukkink, R, Dircks, M., Adriaanse, H., Malek, L T., Sooknanan, R, Lens, P.: NASBA TMisothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV- 1 infection. J. Virol. Meth, 35, 273-286 (1991)
13. Konsensus-Beschluß. Die Bedeutung der Virusbelastung in der Therapie der HIV-Infektion. DAGNÄ-Workshop, Langen 10.05.1996In: Jäger, H. (Hrsg.): Virus Load und AIDS, Thieme, Stuttgart 1997, S. 152
14. Liveday, C.: Persönliche Mitteilung, (Februar 1997)
15. Loveday, C. Kaye, S., Tenant-Flowers, M., Semple, M., Ayliffe, U., Weller, I. V. D., Tedder. R. S.: HIV-1 RNA serum-load and résistent viral genotypes during early zidovudine therapy. Lancet 345, 820-824 (1995)
16. Mellors, J. W., Kingsley, L. A. Rinaldo, ?, Todd, J. A., Hoo, B. S., Kokka, R., Gupta, P.: Quantitäten of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122, 573-579 (1995)
17. O'Brien, W. A., Hartigan, P. M., Martin, D.. Esinhart, J., Hill, A., Benoit, S., Rubin, M., Simberkoff. M. S., Hamilton, J. D.: Changes in plasma HIV-l RNA and CD4+ fymphozyte counts and the risk of progression to AIDS. New.Engl. J. Med. 334, 426431 (1996)
18. Pachl, C., Todd, J. A, Kern, D. G., Sheridan. P. J., Fong, S. J., Stempien, M., Hoo, B., Besemer, D., Yeghiazarian, T., Irvine, B., Kolberg, J., Kokka, R., Beuwald, P., Urdea, M.S.: Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay. J. Acqu. Imm. Def. Syndr. 8, 446-454 (1995)
19. Piatak, M., Saag, M. S., Yang, L. C., Clark, S. J., Kappes. J. C., Luk, K. C., Hahn, B. H., Shaw, G. M., Lifson, J. D.: High levels of HIV-l in plasma during all stages of infection determined by competitive PCR. Science 259, 1749-1753(1993)
20. Revets. H., Marissens, D., De Wit, S., Lacor, P., Clumeck, N., Lauwers, S., Zissis, G.: Comparative Evaluation ofNASBA HIV-l RNA QT.AMPLICORHIV'Monitor, and Quantiplex HIV RNA Assay, three methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. MicrobioJ. 34, 1058-1064 (1996)
21. Schuurman, R., Descamps, D., Weverling, G. J., Kaye, S.. Tijnagel, J., Williams, I., van Leeuwen, R., Tedder, R, Boucher, C. A. A., Brun-Vezinet, F., Loveday, C.: Mult/center Comparison of Three Commercial Methods for Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma. J. Clin. Microbiol. 34, 3016-3022 (1995)
22. Sninsky, J. J., Kwok, S.: The application of quantitative po/ymerase chain reaction to therapeutic monitoring. AIDS 7 (Suppl. 2), 29- 34 (1993)
23. Tiller, F.-W., Wolf, E., Gräbnitz, F., Jägel-Guedes, E, Jäger, H. : Application ofQ-NASBATM for determining HIV-1 viral load in human plasma. Clin. Lab. 41, 769-772(1995)
24. Urdea, M.: Synthesis and characterization of branched DNA (bDNA) for the direct and quantitative detection ofCMV, HBV, HCVandHIV. Clin. Chem. 39, 725-726 CI993)
25. Van Gemen, B., Kievits, T., Schukkink, R, Van Strijp, D., Malek, L. T., Sooknanan, R., Huisman, H. G., Lens, P.: Quantification of HIV-1 RNA in plasma using NASBA TM during a HIV-1 primary infection. J. Wol. Meiti. 43, 177-188 (1993)
26. Volberding, P. A: HIV quantification: Clinical applications. Lancet 347, 71-73 (1996)
27. Weber, B., Melchior, W., Preiser, W., Hess, G., Wahl, M., Braner, J., Doerr, H. W.: Quantitative detection of human immunodeficiency virus (HIV) by the enzymun-test: Comparison with alternative assays and nucleic add sequence-based amplification of HIV type 1RNA. J. Clin. Microbiol. 34. 14401447(1996)
28. Wei. X., Ghosh, S. K., Taylor, M. E, Johnsohn. V. A., Emini, E. A., Deutsch, P., Lifson, J. D., Bonhoeffer. S., Nowak, M. A., Hahn, B. H., Saag, M. S., Shaw, G. M.: Wal dynamics in human immunodeficiency virus typel infection. Nature 373, 117122 (1995)
29. Winters, M. A., Tan, L. B., Katzenstein, D. A., Merigan, T. C.: Biological variation and quality control of plasma human immunodeficiency virus type 1 RAM quantitation by reverse polymerase chain reaction. J. Clin. Microbiol. 31, 2960-2968 [1993)
30. Wong, M. T., Dolan, M. J., Kozlow, E, Doe, R., Melcher, G. P., Burke, D. S., Boswell, R. N., Vahey, M.: Patterns of virus burden in Tce/lphenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons. J. Infect Dis. 173, 877-887(1996)
31. Yen-Liebermann, B., Brambilla, D., Jackson, B., Bremer, J., Coombs, R., Cronin, M., Herman, S., Katzenstein, D., Leung, S., Lin, H. J., Palumbo. P., Rasheed, S., Todd, J.î Vehey, M., Reichelder-fer. P.: Evaluation of a Quality Assurance Program for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma by the AIDS Clinical Trials Group Virology Laboratories. J. Clin. Microbio.l 34, 2695-2701 (1996)